Literature DB >> 19793898

Vaccines: the fourth century.

Stanley A Plotkin1.   

Abstract

Vaccine development, which began with Edward Jenner's observations in the late 18th century, has entered its 4th century. From its beginnings, with the use of whole organisms that had been weakened or inactivated, to the modern-day use of genetic engineering, it has taken advantage of the tools discovered in other branches of microbiology. Numerous successful vaccines are in use, but the list of diseases for which vaccines do not exist is long. However, the multiplicity of strategies now available, discussed in this article, portends even more successful development of vaccines.

Mesh:

Substances:

Year:  2009        PMID: 19793898      PMCID: PMC2786381          DOI: 10.1128/CVI.00290-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  120 in total

1.  Risk of congenital cytomegalovirus infection.

Authors:  Michael J Cannon; Philip E Pellett
Journal:  Clin Infect Dis       Date:  2005-06-01       Impact factor: 9.079

2.  Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge.

Authors:  D E Hassett; J Zhang; J L Whitton
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 3.  DNA shuffling and screening strategies for improving vaccine efficacy.

Authors:  Christopher P Locher; Madan Paidhungat; Robert G Whalen; Juha Punnonen
Journal:  DNA Cell Biol       Date:  2005-04       Impact factor: 3.311

4.  An evaluation of measures of synonymous codon usage bias.

Authors:  J M Comeron; M Aguadé
Journal:  J Mol Evol       Date:  1998-09       Impact factor: 2.395

Review 5.  The prime-boost concept applied to HIV preventive vaccines.

Authors:  J L Excler; S Plotkin
Journal:  AIDS       Date:  1997       Impact factor: 4.177

6.  Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization.

Authors:  D R Sizemore; A A Branstrom; J C Sadoff
Journal:  Vaccine       Date:  1997-06       Impact factor: 3.641

7.  Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties.

Authors:  T J Chambers; A Nestorowicz; P W Mason; C M Rice
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

8.  Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Authors:  Suzanne M Garland; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Diane M Harper; Sepp Leodolter; Grace W K Tang; Daron G Ferris; Marc Steben; Janine Bryan; Frank J Taddeo; Radha Railkar; Mark T Esser; Heather L Sings; Micki Nelson; John Boslego; Carlos Sattler; Eliav Barr; Laura A Koutsky
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

9.  Antibody recognition of a highly conserved influenza virus epitope.

Authors:  Damian C Ekiert; Gira Bhabha; Marc-André Elsliger; Robert H E Friesen; Mandy Jongeneelen; Mark Throsby; Jaap Goudsmit; Ian A Wilson
Journal:  Science       Date:  2009-02-26       Impact factor: 47.728

Review 10.  HEK293 cell line: a vehicle for the expression of recombinant proteins.

Authors:  Philip Thomas; Trevor G Smart
Journal:  J Pharmacol Toxicol Methods       Date:  2005 May-Jun       Impact factor: 1.950

View more
  81 in total

Review 1.  The development of vaccines: how the past led to the future.

Authors:  Stanley A Plotkin; Susan L Plotkin
Journal:  Nat Rev Microbiol       Date:  2011-10-03       Impact factor: 60.633

2.  Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost.

Authors:  Julie E Ledgerwood; Zonghui Hu; Pamela Costner; Galina Yamshchikov; Mary E Enama; Sarah Plummer; Cynthia S Hendel; Lasonji Holman; Brenda Larkin; Ingelise Gordon; Robert T Bailer; Donald M Poretz; Uzma Sarwar; Alisha Kabadi; Richard Koup; John R Mascola; Barney S Graham
Journal:  Contemp Clin Trials       Date:  2015-08-12       Impact factor: 2.226

Review 3.  Systems vaccinology: learning to compute the behavior of vaccine induced immunity.

Authors:  Helder I Nakaya; Shuzhao Li; Bali Pulendran
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2011-10-19

4.  Expression of human rotavirus chimeric fusion proteins from replicating but non disseminating adenovectors and elicitation of rotavirus-specific immune responses in mice.

Authors:  Aurélie Girard; Elodie Roques; Marie-Claude St-Louis; Bernard Massie; Denis Archambault
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

5.  Characterization of structural and immunological properties of a fusion protein between flagellin from Salmonella and lumazine synthase from Brucella.

Authors:  Y Hiriart; A H Rossi; M E Biedma; A J Errea; G Moreno; D Cayet; J Rinaldi; B Blancá; J C Sirard; F Goldbaum; P Berguer; M Rumbo
Journal:  Protein Sci       Date:  2017-03-16       Impact factor: 6.725

6.  Coupling mutagenesis and parallel deep sequencing to probe essential residues in a genome or gene.

Authors:  William P Robins; Shah M Faruque; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

7.  Vaccines today, vaccines tomorrow: a perspective.

Authors:  Christian Loucq
Journal:  Clin Exp Vaccine Res       Date:  2013-01-15

8.  Vaccines, reverse vaccinology, and bacterial pathogenesis.

Authors:  Isabel Delany; Rino Rappuoli; Kate L Seib
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

9.  Vaccines against poverty.

Authors:  Calman A MacLennan; Allan Saul
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

Review 10.  Current state and challenges in developing oral vaccines.

Authors:  Julia E Vela Ramirez; Lindsey A Sharpe; Nicholas A Peppas
Journal:  Adv Drug Deliv Rev       Date:  2017-04-22       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.